New combo therapy aims to keep lung cancer in check
Disease control
Not yet recruiting
This study tests whether a combination of drugs (irinotecan liposome, platinum, an immune checkpoint inhibitor, and anlotinib) can help control extensive small cell lung cancer after initial treatment. About 31 adults with this advanced lung cancer will receive the drug combo as …
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated May 17, 2026 08:17 UTC